切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - haspin kinase - BACE - Inward Rectifier Potassium (Kir) Channels

10 件产品

每页
清除全部
  1. LDN 209929 dihydrochloride
    B7785 LDN 209929 dihydrochloride
    Target: haspin kinase
    Summary: Haspin激酶抑制剂
      <40.58 mg/mL
      <40.58 mg/mL
  2. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  3. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  4. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  5. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  6. AZD3839
    B3224 AZD3839
    Target: BACE
    Summary: BACE1有效的选择性抑制剂
      Soluble in DMSO
  7. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  8. LY2886721
    A8465 LY2886721
     1 Citation
    Target: BACE
    Summary: BACE 抑制剂
      ≥19.52 mg/mL
      insoluble in H2O
  9. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O
  10. (-)-Epigallocatechin gallate (EGCG)
    A2600 (-)-Epigallocatechin gallate (EGCG)
    中文名: (-)-表没食子儿茶素没食子酸酯
    Target: BACE
    Summary: 抗氧化,抗血管生成和抗肿瘤剂
      ≥22.9 mg/mL
      ≥10.9 mg/mL

10 件产品

每页